MLYS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is 0.785, suggesting MLYS is Neutral.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 27.075, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it Buy.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 28.04, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it Buy.

Technical Analysis for MLYS

Technical Sentiment Analysis for Mineralys Therapeutics Inc (MLYS) As of 2026-04-21, Mineralys Therapeutics Inc (MLYS) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 11 technical signals, shows that 6 indicators are flashing buy, while 5 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for MLYS stands at 53.739, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.785, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 73.528 and the Commodity Channel Index (CCI) at 73.12 further confirm a 0.22 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, MLYS is trading below its 60-day moving average of $28.04 and below its 200-day long-term moving average of $30.467. Key price levels to watch include the immediate resistance at $31.373 and strong support at $25.973. A break above $31.373 could signal a bull continuation, while falling below $25.973 may test the next Fibonacci floor at $23.326.

Mineralys Therapeutics Inc (MLYS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	20.573	23.326	25.973	28.726	31.373	34.126	36.773
Fibonacci	23.326	25.389	26.664	28.726	30.789	32.064	34.126

Mineralys Therapeutics Inc (MLYS) Technical Indicators

2026-04-21

Name	Value
RSI_14	53.739
STOCHk_14_3_3	73.528
STOCHd_14_3_3	83.106
CCI_20	73.12
AO_5_34	3.303
MOM_10	0.22
MACD_12_26_9	0.785

Mineralys Therapeutics Inc (MLYS) Relative Strength Index (RSI) is 53.739, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Stochastic Oscillator is 73.528, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Stochastic RSI is 83.106, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) Commodity Channel Index (CCI) is 73.12, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Awesome Oscillator is 3.303, creating a Buy signal.

Mineralys Therapeutics Inc (MLYS) Momentum is 0.22, creating a Buy signal.

Mineralys Therapeutics Inc (MLYS) MACD is 0.785, creating a Buy signal.

Mineralys Therapeutics Inc (MLYS) Moving Average

2026-04-21

Period	Simple	Signal
MA_5	30.032	Sell
MA_10	28.619	Sell
MA_20	27.075	Buy
MA_60	28.04	Buy
MA_200	30.467	Sell
MA_250	27.349	Buy

Mineralys Therapeutics Inc (MLYS) 5-Day simple moving average is 30.032, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 10-Day simple moving average is 28.619, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 27.075, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it a Buy.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 28.04, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it a Buy.

Mineralys Therapeutics Inc (MLYS) 200-Day simple moving average is 30.467, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 250-Day simple moving average is 27.349, while Mineralys Therapeutics Inc (MLYS) share price is $28.285, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for MLYS?

The overall technical consensus for Mineralys Therapeutics Inc (MLYS) is currently Neutral. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 2 sell signals.

What are the key support and resistance levels for Mineralys Therapeutics Inc (MLYS) today?

Based on pivot point calculations, Mineralys Therapeutics Inc (MLYS) has an immediate support level at 25.973 and a major resistance level at 31.373. Traders also monitor the pivot point at 28.726 to determine the intraday trend direction.

Is Mineralys Therapeutics Inc (MLYS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Mineralys Therapeutics Inc (MLYS) is currently 53.739. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Mineralys Therapeutics Inc (MLYS)?

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is 0.785, suggesting MLYS is Neutral. This indicator helps identify potential trend reversals or momentum shifts for Mineralys Therapeutics Inc.

How is Mineralys Therapeutics Inc (MLYS) performing relative to its 200-day moving average?

Mineralys Therapeutics Inc (MLYS) is currently trading at $28.285, which is below its 200-day simple moving average of 30.467. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.